262 related articles for article (PubMed ID: 11964294)
1. Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy.
Wen YJ; Min R; Tricot G; Barlogie B; Yi Q
Blood; 2002 May; 99(9):3280-5. PubMed ID: 11964294
[TBL] [Abstract][Full Text] [Related]
2. Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells.
Wen YJ; Barlogie B; Yi Q
Blood; 2001 Mar; 97(6):1750-5. PubMed ID: 11238117
[TBL] [Abstract][Full Text] [Related]
3. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
[TBL] [Abstract][Full Text] [Related]
4. Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24.
Rew SB; Peggs K; Sanjuan I; Pizzey AR; Koishihara Y; Kawai S; Kosaka M; Ozaki S; Chain B; Yong KL
Clin Cancer Res; 2005 May; 11(9):3377-84. PubMed ID: 15867238
[TBL] [Abstract][Full Text] [Related]
5. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
6. Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.
Yang DH; Kim MH; Lee YK; Hong CY; Lee HJ; Nguyen-Pham TN; Bae SY; Ahn JS; Kim YK; Chung IJ; Kim HJ; Kalinski P; Lee JJ
Ann Hematol; 2011 Dec; 90(12):1419-26. PubMed ID: 21465188
[TBL] [Abstract][Full Text] [Related]
7. Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma.
Chiriva-Internati M; Wang Z; Salati E; Bumm K; Barlogie B; Lim SH
Blood; 2002 Aug; 100(3):961-5. PubMed ID: 12130509
[TBL] [Abstract][Full Text] [Related]
8. [Induction of active antitumor immune response by myeloma idiotype protein-pulsed dendritic cells].
Yin XR; Zhang M; Luo YY; Lin X; He PC; Chen LM; Cai RB; Guo GL
Ai Zheng; 2005 Jun; 24(6):657-62. PubMed ID: 15946473
[TBL] [Abstract][Full Text] [Related]
9. Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells.
Yang DH; Kim MH; Hong CY; Lee YK; Jin CJ; Pham TN; Ahn JS; Bae WK; Kim YK; Chung IJ; Kim HJ; Kalinski P; Lee JJ
Ann Hematol; 2010 Aug; 89(8):795-801. PubMed ID: 20238114
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Jayaprabhu S; Pecorelli S; Parham GP; Cannon MJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):804s-810s. PubMed ID: 11300476
[TBL] [Abstract][Full Text] [Related]
11. Successful generation of sperm protein 17 (Sp17)-specific cytotoxic T lymphocytes from normal donors: implication for tumour-specific adoptive immunotherapy following allogeneic stem cell transplantation for Sp17-positive multiple myeloma.
Chiriva-Internati M; Wang Z; Salati E; Wroblewski D; Lim SH
Scand J Immunol; 2002 Oct; 56(4):429-33. PubMed ID: 12234264
[TBL] [Abstract][Full Text] [Related]
12. Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk.
Chiriva-Internati M; Wang Z; Xue Y; Bumm K; Hahn AB; Lim SH
Eur J Immunol; 2001 Aug; 31(8):2277-83. PubMed ID: 11477539
[TBL] [Abstract][Full Text] [Related]
13. Roles of idiotype-specific t cells in myeloma cell growth and survival: Th1 and CTL cells are tumoricidal while Th2 cells promote tumor growth.
Hong S; Qian J; Yang J; Li H; Kwak LW; Yi Q
Cancer Res; 2008 Oct; 68(20):8456-64. PubMed ID: 18922919
[TBL] [Abstract][Full Text] [Related]
14. Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes.
Azuma T; Otsuki T; Kuzushima K; Froelich CJ; Fujita S; Yasukawa M
Clin Cancer Res; 2004 Nov; 10(21):7402-12. PubMed ID: 15534117
[TBL] [Abstract][Full Text] [Related]
15. Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA.
Milazzo C; Reichardt VL; Müller MR; Grünebach F; Brossart P
Blood; 2003 Feb; 101(3):977-82. PubMed ID: 12393470
[TBL] [Abstract][Full Text] [Related]
16. Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.
Ratta M; Curti A; Fogli M; Pantucci M; Viscomi G; Tazzari P; Fagnoni F; Vescovini R; Sansoni P; Tura S; Lemoli RM
Exp Hematol; 2000 Aug; 28(8):931-40. PubMed ID: 10989194
[TBL] [Abstract][Full Text] [Related]
17. Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.
Hong S; Li H; Qian J; Yang J; Lu Y; Yi Q
Clin Exp Immunol; 2012 Nov; 170(2):167-77. PubMed ID: 23039887
[TBL] [Abstract][Full Text] [Related]
18. Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.
Lee JJ; Choi BH; Kang HK; Park MS; Park JS; Kim SK; Pham TN; Cho D; Nam JH; Kim YJ; Rhee JH; Yang DH; Kim YK; Kim HJ; Chung IJ
Leuk Lymphoma; 2007 Oct; 48(10):2022-31. PubMed ID: 17917970
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes.
Hayashi T; Hideshima T; Akiyama M; Raje N; Richardson P; Chauhan D; Anderson KC
Blood; 2003 Aug; 102(4):1435-42. PubMed ID: 12714512
[TBL] [Abstract][Full Text] [Related]
20. Induction of T cell responses against autologous ovarian tumors with whole tumor cell lysate-pulsed dendritic cells.
Zhao X; Wei YQ; Peng ZL
Immunol Invest; 2001 Feb; 30(1):33-45. PubMed ID: 11419910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
